Isolation of cyclotron produced 205Bi, 206Bi and 203Pb using a lead-selective extraction chromatographic resin

被引:7
作者
Henriksen, G [1 ]
Hoff, P [1 ]
机构
[1] Univ Oslo, Dept Chem, Oslo, Norway
关键词
D O I
10.1016/S0969-8043(97)00251-0
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The lead-selective extraction chromatographic resin Pb-SpecTM has been evaluated for the separation of Bi-radioisotopes from cyclotron irradiated lead targets. The objective of the work was to obtain sources of 205,206Bi which could be used in the chemical and biological evaluation of Bi-compounds intended for use in targeted radiotherapy. It was found that two consecutive separations using Pb-SpecTM provide a simple and rapid procedure for the preparation of 205,206Bi sources of the desired quality. The procedure may also be used for the production of 203Pb sources.; The lead-selective extraction chromatographic resin Pb-SpecTM has been evaluated for the separation of Bi-radioisotopes from cyclotron irradiated lead targets. The objective of the work was to obtain sources of 205,206Bi which could be used in the chemical and biological evaluation of Bi-compounds intended for use in targeted radiotherapy. It was found that two consecutive separations using Pb-SpecTM provide a simple and rapid procedure for the preparation of 205,206Bi sources of the desired quality. The procedure may also be used for the production of 203Pb sources.
引用
收藏
页码:357 / 359
页数:3
相关论文
共 12 条
[1]   SYNTHESIS OF C-FUNCTIONALIZED TRANS-CYCLOHEXYLDIETHYLENETRIAMINEPENTA-ACETIC ACIDS FOR LABELING OF MONOCLONAL-ANTIBODIES WITH THE BISMUTH-212 ALPHA-PARTICLE EMITTER [J].
BRECHBIEL, MW ;
GANSOW, OA .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1992, (09) :1173-1178
[2]  
HASSFJELL SP, 1997, IN PRESS NUCL MED BI
[3]  
HORWITZ EP, 1994, ANAL CHIM ACTA, V292, P263
[4]   BISMUTH-212-LABELED ANTI-TAC MONOCLONAL-ANTIBODY - ALPHA-PARTICLE-EMITTING RADIONUCLIDES AS MODALITIES FOR RADIOIMMUNOTHERAPY [J].
KOZAK, RW ;
ATCHER, RW ;
GANSOW, OA ;
FRIEDMAN, AM ;
HINES, JJ ;
WALDMANN, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (02) :474-478
[5]  
KOZAK RW, 1990, J IMMUNOL, V144, P3417
[6]   CYCLOTRON PRODUCTION OF NO-CARRIER-ADDED BI-206 (6.24 D) AND BI-205 (15.31 D) AS TRACERS FOR BIOLOGICAL STUDIES AND FOR THE DEVELOPMENT OF ALPHA-EMITTING RADIOTHERAPEUTIC AGENTS [J].
LAGUNASSOLAR, MC ;
CARVACHO, OF ;
NAGAHARA, L ;
MISHRA, A ;
PARKS, NJ .
APPLIED RADIATION AND ISOTOPES, 1987, 38 (02) :129-137
[7]   RADIOIMMUNOTHERAPY WITH ALPHA-PARTICLE EMITTING IMMUNOCONJUGATES [J].
MACKLIS, RM ;
KINSEY, BM ;
KASSIS, AI ;
FERRARA, JLM ;
ATCHER, RW ;
HINES, JJ ;
COLEMAN, CN ;
ADELSTEIN, SJ ;
BURAKOFF, SJ .
SCIENCE, 1988, 240 (4855) :1024-1026
[8]  
MIRZADEH S, 1993, RADIOCHIM ACTA, V60, P1
[9]   THE DEVELOPMENT OF ALPHA-EMITTING RADIONUCLIDE LEAD 212 FOR THE POTENTIAL TREATMENT OF OVARIAN-CARCINOMA [J].
ROTMENSCH, J ;
ATCHER, RW ;
HINES, J ;
GRDINA, D ;
SCHWARTZ, JS ;
TOOHILL, M ;
HERBST, AL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 160 (04) :789-797
[10]  
RUEGG CL, 1990, CANCER RES, V50, P4221